medigraphic.com
ISSN 0035-0052 (Impreso)

2001, Número 2

<< Anterior Siguiente >>

Rev Mex Pediatr 2001; 68 (2)


Atrofia muscular espinal tipo I. Reporte de un caso atípico

Garza AAG, Rodríguez BR, López EJA, Nieto SA

Idioma: Español
Referencias bibliográficas: 25
Paginas: 69-71
Archivo PDF: 67.27 Kb.


RESUMEN

La atrofia muscular espinal tipo I es una enfermedad degenerativa de las neuronas motoras del asta anterior de la médula espinal, que se inicia en la vida fetal; afecta los músculos voluntarios, en forma proximal, sin afectar su sensibilidad. Se identifica por particularidades histopatológicas típicas y un cuadro clínico característico, pero no patognomónico; sin embargo 15% de los casos son atípicos. El diagnóstico se confirma por estudios de laboratorio y gabinete; no hay tratamiento efectivo y su pronóstico es malo. En este informe se presenta un caso clínico atípico.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Birnkrant DJ, Pope JF, Martin JE, Repucci AH. Treatment of type I Spinal Muscular Atrophy with noninvasive ventilation and gastrostomy feeding. Pediatr Neurol 1998; 18: 407-10.

  2. Bach JR, Wang TG. Noninvasive long-term ventilatory support for individuals with spinal muscular atrophy and functional bublbar musculature. Arch Phys Med Rehabil 1995; 76: 213-7.

  3. Pérez A, Mullot R, Vardon G. Thoracoabdominal pattern of breathing in neuromuscular disorder. Chest 1996; 110: 454-61.

  4. Chou SM, Wang HS. Aberrant glycosilation/phosphorylation in chromatolytic motoneurons of Werdning- Hoffmann disease. J Neurol Sci 1997; 25(152): 198-209.

  5. MacLean Md, Roy N, MacKenzie AE. Two 5q13 simple tandem repeat loci are in linkage disequilibrium with type I spinal muscular atrophy. Hum Mol Genet 1994; 3: 1951-6.

  6. Parsons DW, McAndrew PE, Monani UR. An II base pair duplication in exons 6 of the SMN gene prodeces a type I spinal muscular atrophy (SMA) phenotype: further evidence for SMN as the primary SMA-determining gene. Hum Mol Gen 1996; 5: 1727-32.

  7. Yaamanouchi Y, Yaamanouchi H, Becker LE. Synaptic alterations of anterior horn cells in Werdning-Hoffmann disease. Pediatric Neurol 1996; 15: 32-5.

  8. Burlet P, Burglen L. Large scale deletions of the 5q13 region are specific to Werdning-Hoffmann disease. J Med Genet 1996; 33: 281-3.

  9. Ohkura M, Mitsudome A, Yasumoto S. Werndnig-Hoffmann disease type I with progressive ophthalmoplegia and ptosis. No To Hattatsu 1996; 28: 332-5.

  10. Baumgarther MR, Verhoeven NM, Jakobs C. Defective peroxisome biogenesis with a neuromuscular disorder resembling Werdning-Hoffmann disease. Neurology 1998; 51: 1427-32.

  11. Vajsar J, Balslev T, Ray PN. Congenital cytoplasmic body myopathy with survival motor neuron gene deletion or Werdning-Hoffmann disease. Neurology 1998; 51: 873-5.

  12. Colomer J. Childhood spinal muscular atrophies. Neurologia 1996; 11(Suppl 5): 29-42.

  13. Lefebver S, Burglen L, Frezal J. The role of the SMN gene proximal spinal muscular atrophy. Hum Mol Genet 1998; 7: 1531-6.

  14. Iannaccone ST. Spinal muscular atrophy. Semin Neurol 1998; 18: 19-26.

  15. Zerres K, Rudnik-Shoneborn S. Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modifications of existing classifications. Arch Neurol 1995; 52: 518-23.

  16. Melki J, Sheth P, Abdelhak S, Burlet P. Mapping of acute (type I) spinal muscular atrophy to chromosome 5ql2-ql4. The French Spinal Muscular Atrophy Investigators. Lancet 1990; 336: 271-3.

  17. Salhi MA, Mahdi AH, Jarallah AS. Childhood neuromuscular disorders: a decade’s experience in Saudi Arabia. Ann Trop Pediatric 1996; 16: 271-80.

  18. Rudnik-Schoneborn S, Forkert R. Clinical spectrum and diagnostic criteria of infantile spinal muscular atrophy: further delineation on the basis of SMN gene deletions findings. Neuropediatrics 1996; 27(1): 8-15.

  19. Spiegel R, Hagman A, Bolthauser E. Molecular genetic diagnosis and deletions analysis in type I-III spinal muscular atrophy. Schweiz Med Wochenschr 1996; 126(21): 907-14.

  20. Behrman: Nelson. Textbook of Pediatrics 15th ed. Chapter 563: 1757-1758.

  21. Farreras. Tratado de Medicina Interna l4ª ed. 2000, Editorial Harcourt-Brace.

  22. Otero-Siliceo E, Arriada-Mendicoa N, Corona-Vázquez T. Frequency of motor neuron disease in a Mexico City referral center. Rev Invest Clin 1997; 49: 445-8.

  23. MacKenzie A E, MD, PhD, Jacob P, MD, FRCP, Surth L, MD, PhD. Genetic heterogeneity in spinal muscular atrophy: A linkage analysis based assessment. Neurology 1994; 33: 419-924.

  24. Thompson TG, DiDonato C J, Simard LR. A novel cDNA detects homozygous microdeletions in greater than 50% of type I spinal muscular atrophy patients. Nature Genetics 1995; 9: 56-62.

  25. Schimdt R, Voit Th. Ultrasound measurement of quadriceps muscle in the first year of life. Normal values and application to spinal muscular atrophy. Neuropediatrics 1993; 24: 36-42.




2020     |     www.medigraphic.com